BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:37 PM
 | 
Mar 25, 2010
 |  BC Extra  |  Company News

Transcept gives Intermezzo update

Transcept Pharmaceuticals Inc. (NASDAQ:TSPT) said it plans to resubmit an NDA for Intermezzo zolpidem in late 4Q10 after FDA agreed with the company's plans to conduct a highway driving study to assess next day residual effects of the insomnia compound. The company plans to conduct...

Read the full 215 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >